Pilocarpine for Sjögren’s: Four Trial Checks

Dry mouth can interrupt a meal or conversation, but its cause needs assessment before another product is added. NIDCR¹ advises a medical-history and medicine review; a clinician may also measure saliva or request blood tests. Medicines, Sjögren’s disease and cancer treatment are among the causes.¹

Trial population

P92-01 randomized 373 adults with Sjögren’s and residual saliva production to 5-mg or 2.5-mg pilocarpine tablets or placebo four times daily for 12 weeks. MGI Pharma funded it; several authors had company affiliations.²

Meaning of response

61.3% on 5 mg versus 31.1% on placebo reported overall mouth improvement (P ≤ .001). Response meant above 55 on a 100-mm change scale, not symptom disappearance. The 2.5-mg group did not significantly outperform placebo.²

Saliva measurements 60 minutes after dosing also favored 5 mg. That does not establish cavity prevention.²

Missing follow-up

324 completed. Analyses required a postdose assessment, using the last available, sometimes before week 12.²

Sweating and suitability

Sweating occurred in 55/127 (43.3%) on 5 mg versus 9/125 (7.2%) on placebo.²

The current US tablet label contraindicates uncontrolled asthma, pilocarpine allergy and conditions where pupil constriction is undesirable, including acute iritis and narrow-angle glaucoma. Heart disease, controlled asthma, chronic bronchitis and COPD require particular review. Night-time visual disturbance may affect driving.³

Excessive sweating can cause dehydration if fluid intake is inadequate. Discuss beta blockers, inhaled anticholinergics and other medicines with the prescriber. Also mention liver disease, pregnancy plans or breastfeeding; the label describes additional precautions for these circumstances. Trial schedules are not instructions to start or adjust treatment.³

At review, name one task: swallowing lunch, speaking comfortably or sleeping without water. Ask when benefit will be assessed and how to report sweating.¹

NIDCR¹ recommends continuing oral care and dental check-ups because persistent dryness increases tooth-decay and fungal-infection risks. A medicine that makes your mouth feel wetter does not replace that care.¹

“Supporting Saliva” in Is It My Breath? places supervised prescription stimulants alongside comfort measures and a question about extra fluoride. Bring your medicine list and symptom notes to that discussion.